Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Using tDCS in Speech-based Stroke Rehabilitation

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a non-significant risk to participants. tDCS provides low intensity neural stimulation which has been shown to facilitate motor learning in other domains of stroke rehabilitation such as arm motor learning but the potential to enhance speech motor learning has not been explored. This will be examined with a series of single-case experimental designs.

Who May Be Eligible (Plain English)

Who May Qualify: - Right-handed - Monolingual (English) - Single left-hemisphere CVA - A minimum of six months post-stroke - Clinical diagnosis of apraxia of speech - Normal speech perception - Passing score on the hearing screening. Who Should NOT Join This Trial: - Diagnosis of laryngeal voice disorder - Dysarthria - History of speech impairment prior to CVA - Presence of potential tDCS risk factors: damaged skin at site of stimulation; - Presence of electrically or magnetically activated implant (including pacemaker); - metal in any part of their body; - history of medication-resistant epilepsy in the family; - past history of seizures or unexplained spells of loss of consciousness. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Right-handed * Monolingual (English) * Single left-hemisphere CVA * A minimum of six months post-stroke * Clinical diagnosis of apraxia of speech * Normal speech perception * Passing score on the hearing screening. Exclusion Criteria: * Diagnosis of laryngeal voice disorder * Dysarthria * History of speech impairment prior to CVA * Presence of potential tDCS risk factors: damaged skin at site of stimulation; * Presence of electrically or magnetically activated implant (including pacemaker); * metal in any part of their body; * history of medication-resistant epilepsy in the family; * past history of seizures or unexplained spells of loss of consciousness.

Treatments Being Tested

DEVICE

Soterix 1x1 line tDCS low-intensity stimulator

Introduction of the independent variable (treatment) across three different points in time. Participants will be randomly assigned to have each treatment phase begin after 3, 4, or 6 baseline sessions. This current stimulates the cortex, with anodal stimulation leading to a depolarized state in which neurons are more likely to fire.

DEVICE

Sham

Patients will have two electrodes applied (one anode, one cathode) administering no stimulation

Locations (2)

New York University School of Medicine
New York, New York, United States
Burke Rehabilitation Hospital
White Plains, New York, United States